WGS Q1 2023 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q1 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$43M-20.0% YoY

Gross Profit

$15M35.3% margin

Operating Income

-$60M-139.9% margin

Net Income

-$61M-141.4% margin

EPS (Diluted)

$-3.04

QoQ Revenue Growth

-29.7%

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$56M

Stock-Based Comp.

$48,000

Balance Sheet

Total Assets

$545M

Total Liabilities

$217M

Stockholders' Equity

$328M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$54M	-20.0%
Gross Profit	$15M	$6M	+170.9%
Operating Income	-$60M	-$89M	+32.4%
Net Income	-$61M	-$77M	+20.7%